Thymic T cell development is initiated from bone-marrow-derived multi potent thymus-seeding progenitors. During the early stages of thymocyte differentiation, progenitors become T cell restricted. However, the cellular environments supporting these critical initial stages of T cell development within the thymic cortex are not known. Here we use the dependence of early, c-Kit-expressing thymic progenitors on Kit ligand (KitL) to show that CD4 − CD8 − c-Kit + CD25 − DN1-stage progenitors associate with, and depend on, the membrane-bound form of KitL (mKitL) provided by a cortex-specific KitL-expressing vascular endothelial cell (VEC) population. In contrast, the subsequent CD4 − CD8 − c-Kit + CD25 + DN2-stage progenitors associate selectively with cortical thymic epithelial cells (cTECs) and depend on cTEC-presented mKitL. These results show that the dynamic process of early thymic progenitor differentiation is paralleled by migration-dependent change to the supporting niche, and identify VECs as a thymic niche cell, with mKitL as a critical ligand.
A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitors Thymic T cell development is initiated from bone-marrow-derived multi potent thymus-seeding progenitors. During the early stages of thymocyte differentiation, progenitors become T cell restricted. However, the cellular environments supporting these critical initial stages of T cell development within the thymic cortex are not known. Here we use the dependence of early, c-Kit-expressing thymic progenitors on Kit ligand (KitL) to show that CD4 − CD8 − c-Kit + CD25 − DN1-stage progenitors associate with, and depend on, the membrane-bound form of KitL (mKitL) provided by a cortex-specific KitL-expressing vascular endothelial cell (VEC) population. In contrast, the subsequent CD4 − CD8 − c-Kit + CD25 + DN2-stage progenitors associate selectively with cortical thymic epithelial cells (cTECs) and depend on cTEC-presented mKitL. These results show that the dynamic process of early thymic progenitor differentiation is paralleled by migration-dependent change to the supporting niche, and identify VECs as a thymic niche cell, with mKitL as a critical ligand.
The niches that maintain tissue stem cells have been extensively characterized over the past three decades, leading to a much improved understanding of their constituent cell types and extracellular matrix components, and the signals these provide to dynamically regulate stem cell behaviour 1, 2 . In contrast, little is known about the physical environments dedicated to supporting the progenitor cells derived from tissue stem cells. This is due to several factors, including their transient nature and changing phenotype during the differentiation process, contrasting with the relative stability and phenotypic homogeneity of stem cell populations. That specific progenitor niches exist was first suggested by the identification of erythroid islands, where central macrophages provide support for developing erythroblasts 3 . More recently, a Cxcl12-dependent, bone-associated lymphoid progenitor niche was proposed 4, 5 , the latter study emphasizing the usefulness of critical ligands in the identification of essential niche cell types.
T cell development is initiated in the thymic cortex, where multipotent thymus-seeding progenitors enter through P-selectin-mediated extravasation at the cortico-medullary junction 6 . As they migrate through the thymic cortex they progress through the CD4/CD8 double-negative stages 1-4 (DN1-4) of thymocyte differentiation to form CD4 + CD8 + thymocytes, which then migrate to the medulla to undergo negative selection where self-reactive T cells are eliminated 7 . DN3 thymocytes are the first fully T-cell-restricted progenitors, whereas DN1 and DN2 cells undergo expansion and gradual lineage restriction. This process is supported by Dll4 expressed on cortical thymic epithelial cells (cTECs) as a critical Notch ligand for DN1/DN2 thymocytes 8, 9 . Other regulators of thymic progenitor pool size and progression include interleukin (IL-)7, Ccl19, Ccl25 and Cxcl12 (refs [10] [11] [12] [13] [14] , whereas BMP4 and Wnt4 are involved in thymocyte differentiation [15] [16] [17] . However, although these factors are expressed in the thymic stroma 18 , their cellular source(s), and hence the physical niches in which thymic progenitors develop, are yet to be identified.
The c-Kit receptor is selectively expressed on early thymic progenitors (DN1/DN2). A thymic Kit ligand (KitL) source is critical for early thymic progenitor (ETP) development, as KitL-deficient thymuses transplanted into wild-type recipient mice show defective T cell development 19 , but the cell type(s) providing the ligand remain unknown. Moreover, KitL exists both as a membrane-associated (mKitL) and a secreted (sKitL) form, and little is known about the specific physiological roles of these two KitL molecules 20 , a question particularly relevant to the identification of cellular niches supporting defined progenitors through direct cell-cell interaction. Supplementary  Table 5 . (c) Schematic representation of the Kitl-CreER T 2 -IRES-tdTomato BAC transgene. IRES, internal ribosomal entry site; pA, polyadenylation site; Cds, coding sequence. (d) Double immunofluorescence analysis of a thymic frozen section from a Kitl-tdTomato tg/+ mouse using antibodies against KitL (left; red) and tdTomato (centre; green). KitL/tdTomato co-localization is also shown (right, merge). Scale bars, 100 µm. (e) Representative flow cytometric analysis of tdTomato expression in the indicated thymic stromal cell populations from Kitl-tdTomato tg/+ mice and wild-type controls. The fraction of tdTomato + cells is shown for each population.
Here, we set out to define the cellular source(s) and molecular form of KitL involved in supporting the earliest stages of c-Kit + multi-potent thymocyte progenitor development. We observed that, in addition to TECs, a distinct subset of vascular endothelial cells (VECs), selectively located in the thymic cortex, expressed high levels of KitL. DN1 thymocytes were closely associated with mKitL-expressing VECs, and VEC-specific loss of mKitL resulted in a strong depletion of DN1 thymocytes, including ETPs. DN2 thymocytes did not associate closely with VECs, and were instead principally dependent on mKitL presented by TECs for their maintenance. Overall, these results identify thymic VECs as a previously unknown and critical component of the developing thymocyte niche, and mKitL as a critical niche-presented ligand, demonstrating that thymic progenitor niches are dynamic structures to which distinct stromal cell populations contribute in a progenitor differentiation stage-dependent manner.
RESULTS
To identify the thymic stromal cells with the potential to support ETP differentiation through KitL production we first fractionated the thymic stroma into its main components: vascular endothelial cells (VEC), mesenchymal cells (MC) and thymic epithelial cells (TEC) by cell sorting. TECs were further subdivided into cortical (cTEC) and medullary (mTEC) subtypes 21 ( Fig. 1a and Supplementary Fig. 7 ). We next determined the expression of Kitl in these cell types. We observed that Kitl messenger RNA was expressed in VECs, MCs and cTECs, with VECs expressing the highest levels, but barely detectable in mTECs ( Fig. 1b ). To quantify Kitl expression at the single-cell level, and to visualize and prospectively isolate Kitl-expressing cells, we generated a BAC transgenic reporter mouse line expressing tdTomato from the Kitl promoter ( Fig. 1c) of tdTomato and KitL in thymic sections ( Fig. 1d ). Flow cytometric analysis of Kitl-tdTomato tg/+ thymuses showed that, consistent with the gene expression analysis, expression of Kitl-tdTomato-derived tdTomato (henceforth, KT) in TECs was confined to cTECs, with no expression detectable in mTECs ( Fig. 1e ). Significantly, VECs contained distinct KT + and KT − populations, the former comprising approximately 70% of the VEC population. Finally, a minor fraction (about 20%) of MCs were KT + . The abundance of distinct KT + VECs, combined with their high Kitl expression, was consistent with a role for this cell population in c-Kit + thymocyte differentiation.
To localize thymic KT + cells we performed immunohistochemistry using markers specific for VEC (CD31), cTEC (keratin 8 (K8)), and mTECs (K5). KT expression was confined to the cortical side of the cortico-medullary junction, and co-localized with both CD31 and K8, but not K5, consistent with the flow cytometric analysis ( Fig. 2a-l ). Simultaneous labelling of tdTomato, cTECs (Ly51), mTECs (UEA-1) and VECs (CD31) confirmed the selective expression of KT in cortically located VECs and cTECs ( Fig. 2m-q) . Strikingly, whereas around 60% of the cortical vascular structures were KT + , no KT + VECs were observed in the medulla (Fig. 2r ). The KT + VEC population therefore defines a distinct VEC subset exclusive to the thymic cortex, the area of ETP immigration.
To explore the molecular differences between KT + and KT − stromal cell populations, we performed RNA sequencing-based global gene expression profiling, comparing KT + and KT − VECs, as well as cTECs and mTECs. This analysis showed that Kitl, Notch ligands (Dll1, Dll4, Jag1, Jag2), Bmp4, Wnt4, Ccl25 and Cxcl12 were expressed more highly by cTECs compared with mTECs, consistent with their importance for DN1/DN2 differentiation. Notably, several ligands (Kitl, Cxcl12, Dll4, Jag1, Jag2) were expressed at higher or DN2, N = 127 from three biological replicates. (g) Immunofluorescence analysis of thymic sections with antibodies against CD31 (green); intracellular KitL (pink; used to generate data in a) was used as a platform to generate a random distribution of DN1 and DN2 cells. The original DN1 and DN2 cell staining was removed and replaced with randomly distributed red (DN1) and blue (DN2) dots that resembled the size and the in vivo frequency for these cells. (h) Distribution of the distances between ICKitL + VECs (DN1) versus ICKitL + VECs (random). The significance of the difference in the distance distribution was calculated using the Kolmogorov-Smirnov test. P value is shown. DN1, N = 189 (from c); random, N = 80. (i) Distribution of the distances between ICKitL + VECs (DN2) versus ICKitL + VECs (random). The significance of the difference in the distance distribution was calculated using the Kolmogorov-Smirnov test. P value is shown. DN2, N = 153 (from c); random, N = 120. comparable levels by KT + VECs, supporting a niche role for this distinct cortical VEC population ( Fig. 3a) . To confirm the identity of the sorted populations we examined the expression of Cdh5 and
Tek (encoding vascular endothelial (VE)-cadherin and angiopoietin receptor; Fig. 3b ), and Foxn1 and Epcam (epithelial/TEC-specific markers; Fig. 3c ), and found these to be selectively expressed in the Flt3 Supplementary Table 5 . Supplementary Table 5 .
VEC and TEC populations, respectively. To validate the TEC subfractionation we examined expression of Psmb11 and Ly75 (encoding the cTEC-specific β-5T proteasome subunit and the CD205 cTEC marker, respectively; Fig. 3d ), and Aire and Cd80 (both mTECspecific genes; Fig. 3e ) and found the expected selective expression in cTECs and mTECs populations. Comparison of KT + and KT − VEC populations showed higher expression of arterial markers (Depp, Hey1, Efnb2; Fig. 3f ) in KT + VECs, and of the venous marker Nf2r2 (ref. 22) and Vwf in KT − VECs (Fig. 3g ). We also confirmed expression of the mKitL-encoding Kitl splice variant lacking exon 6 in KT + VECs and cTECs, with low expression in KT − VECs and mTECs ( Fig. 3h , expression data summarized in Supplementary  Fig. 1a ). Finally, we measured the expression of Kitl in single TECs and VECs, confirming high and consistent expression of Kitl mRNA in KT + VECs compared with KT − VECs, and cTECs compared with mTECs. This analysis also showed that Kitl and Cxcl12 are co-expressed by virtually all cTECs and KT + VECs (Fig. 3i,j and Supplementary Fig. 1b ). These findings identified molecularly distinct thymic VEC subpopulations. In particular, the KT + VEC subset exhibited arterial identity, and expressed many ligands necessary for thymocyte development, including Kitl and Cxcl12. Together with their selective cortical localization this suggested that KT + VECs could play a role in promoting thymic progenitor development. We therefore examined the location of DN1 (defined as c-Kit + CD25 − ) and DN2 (c-Kit + CD25 + ) cells relative to VECs and cTECs, using ICKitL-specific antibody to specifically label mKitL-expressing cells. Quantification of the distance between c-Kit + thymocytes and mKitL + VECs showed that most DN1 cells were located in close proximity (<10 µm) to mKitL + VECs (56%; median distance 7 µm), whereas only a small fraction of DN2 cells were located <10 µm from mKitL + VECs (12%; median distance 28 µm; Fig. 4a-c) . In contrast, all c-Kit + thymocytes were located <10 µm from a mKitL + cTEC ( Fig. 4d-f ), consistent with the dense network of cTECs within the cortex, and their ubiquitous KitL expression. Comparison of DN1 and DN2 localization to that obtained by randomly distributed cells confirmed that the proximity of DN1 and DN2 cells to vascular endothelium was statistically significant ( Fig. 4g-i) .
Their proximity to c-Kit + DN1 cells raised the possibility of mKitL + VECs acting as part of an ETP niche. We therefore examined the role of mKitL expressed on VECs, because its membrane association should confine its action to directly adjacent cells. The physiological role of mKitL has previously been examined using the Steel-Dickie (Sl d ) mutation, which generates a frame shift mutation eliminating the transmembrane domain of KitL (refs 23,24) . It is assumed that sKitL is expressed normally by the Sl d allele. However, the KitL serum Cell frequency relative to control Fig. 2a ). The described effects of the Sl d mutation [25] [26] [27] , in particular in combination with a Steel null allele, therefore cannot be attributed solely to the loss of mKitL. To analyse mKitL function in specific cell types we therefore generated a mouse line where exon 7 of the Kitl gene, encoding the transmembrane domain, is flanked by loxP sites (Kitl LEx7 ; Supplementary Fig. 2b ). Germline deletion of this exon (generating the Kitl Ex7 allele) still allows production of sKitL with the same biological activity as that produced by the Sl d allele ( Supplementary Fig. 2c,d ).
Mice homozygous for theKitl Ex7 allele showed the perinatal lethality, and severe developmental and haematopoietic abnormalities normally associated with Steel alleles 28 , including loss of thymic cellularity. Serum KitL in Kitl Ex7/ Ex7 mice (henceforth, Ex7 mice) was reduced ( Supplementary Fig. 2e ), but only to a level similar to that of Sl/+ mice (Supplementary Fig. 2a ; P = 0.65), a level sufficient to sustain normal bone marrow lymphopoiesis and thymopoiesis in the presence of mKitL ( Supplementary Fig. 2f -i). Whereas the strong phenotype of Ex7 mice, compared with Sl/+ mice, supported a critical physiological role of mKitL, their severe and pleiotropic phenotype precluded conclusions about the cellular origin of the thymic defect.
To determine the contribution of VEC-associated mKitL to early thymic progenitor development we deleted Kitl exon 7 using two different VEC-specific Cre drivers, Tie2-Cre (ref. 29 ) and Supplementary Table 5 .
Pdgfb-CreER T 2 (ref. 30 ). To confirm their selective expression in thymic VECs we performed lineage tracing (Tie2-Cre) using the Rosa26-EYFP reporter 31 and direct readout of EGFP expression (using the IRES-EGFP moiety of thePdgfb-CreER T 2 allele), respectively ( Supplementary Fig. 3a-d ). In both cases fluorescence was observed in 80-90% of VECs, but not in other stromal cells.
We induced VEC-specific Kitl Ex7 deletion using the Tie2-Cre and Pdgfb-CreER T 2 drivers, in the latter case inducing recombination with tamoxifen, generating Tie2 Ex7 and Pdgfb Ex7 mice, respectively. Analysis 7 days after the last tamoxifen injection showed no significant effect of tamoxifen on thymopoiesis, nor did Pdgfb-CreER T 2 activation significantly affect thymopoiesis or bone marrow lymphoid progenitor populations ( Supplementary  Fig. 3g-k) . Quantitative PCR (qPCR) using an amplicon spanning exons 7 and 8 confirmed loss of Kitl exon 7, without any significant depletion of total Kitl mRNA (measured using an exon 2-3-spanning amplicon; Fig. 5a ). The deletion efficiencies obtained were high for both Tie2-Cre (86%) and Pdgfb-CreER T 2 (97%). Combined Tie2-Cre and Pdgfb-CreER T 2 (generating Tie2/Pdgfb Ex7 mice) achieved near-complete (>99%) exon 7 deletion.
VEC-specific mKitL loss resulted in a 50% decrease in thymocyte numbers (Fig. 5b ). This was accompanied by a selective and much more extensive loss of the earliest c-Kit + thymic progenitors, as Flt3 + DN1 cells, and downstream Flt3 − DN1 and DN2 thymocyte progenitors were all reduced following recombination with either driver, and in particular by their combined effect (Fig. 5c,d) .
Correcting for the diminished size of the thymus, depletion was most evident for the earliest progenitors. When the VEC-specific Cre lines were combined, Flt3 + DN1 cells were decreased 30-fold, Flt3 − DN1 cells 16-fold, and DN2 cells 8-fold ( Fig. 5e) , showing that VECassociated mKitL is most critically required in the DN1 compartment, consistent with the close association of this progenitor population with mKitL + vascular structures. Importantly, the severity of the phenotype correlated with the efficiency of Ex7 deletion, being most profound in the Tie2/Pdgfb Ex7 genotype, supporting that the phenotype observed was a direct effect of mKitL depletion. The decrease in thymic progenitors did not result from disrupted thymic architecture ( Supplementary Fig. 4 ), and proportional numbers of stromal cell types were maintained ( Supplementary Fig. 5a ). Finally, there was no detectable impairment of subsequent thymocyte differentiation stages, but rather a partial recovery at the CD4 and CD8 single-positive stages (SP4 and SP8, respectively; Supplementary Fig. 5b ). The observed progenitor phenotype and decreased thymus cellularity was therefore due to a direct and selective effect on the earliest DN1 and DN2 thymocyte progenitors, rather than indirect effects on stromal cells or subsequent thymocyte differentiation stages. As recombination was induced systemically in VECs, potentially decreasing availability of circulating KitL, we examined serum KitL levels, observing a 35% decrease in Tie2/Pdgfb Ex7 mice (Fig. 5f) and thymopoiesis in Sl/+ mice ( Supplementary Fig. 2a ), and we observed no changes to bone marrow lymphopoiesis on VEC-specific mKitL deletion ( Supplementary Fig. 6a,b) .
To investigate the role of mKitL in cTECs we used the Foxn1-Cre driver 32 . We confirmed its TEC-selective and efficient recombination by lineage tracing (>98% of TECs YFP-labelled; Supplementary  Fig. 3e,f) . Foxn1 Ex7 mice were generated by crossing the Foxn1-Cre (ref. 32) allele to the Kitl LEx7 allele. By qPCR we observed nearcomplete deletion of Kitl exon 7 in Foxn1 Ex7 TECs (>99%), with only a mild (20%) decrease in the total Kitl mRNA level (Fig. 6a ). Also here thymus cellularity was decreased (Fig. 6b) , with a significant depletion of Flt3 + DN1 (fourfold) and Flt3 − DN1 cells (fourfold). However, in contrast to VEC-specific mKitL loss, an even more profound loss of DN2 cells (15-fold) was observed ( Fig. 6c-e ), consistent with the DN2 population lacking proximity to mKitL + VECs and being principally supported by mKitL + TECs. Consistent with the restricted Foxn1-Cre recombination pattern we saw no significant decrease of circulating KitL (Fig. 6f ), and no changes in bone marrow lymphopoiesis ( Supplementary Fig. 6c,d) , thymic morphology ( Supplementary Fig. 4 ), proportions of thymic stromal cells ( Supplementary Fig. 5a ) or downstream thymic progenitor subsets ( Supplementary Fig. 5c ) in Foxn1 Ex7 mice. Finally, combining VEC and TEC deletion we observed the expected decrease in thymic cellularity (Fig. 6g ), and achieved a synergistic depletion of both DN1 and DN2 cells (>20-fold relative decrease; Fig. 6h ,i), with serum sKitL maintained above the level compatible with normal lymphopoiesis (Fig. 6j ). Also in these mice bone marrow lymphoid progenitor numbers, thymic morphology, and frequencies of stromal cells and partial recovery of subsequent thymocyte differentiation stages were preserved ( Supplementary Figs 4, 5c and 6e,f).
To address how mKitL promotes thymic progenitor differentiation we performed Rosa26-CreER T 2 -mediated mKitL depletion in primary thymic stromal cultures (Fig. 7a ). Co-culture of wild-type DN1 cells with Ex7 stroma resulted in significantly decreased thymic progenitor expansion compared with wild-type control cultures (Fig. 7b ). We therefore labelled input cells with carboxyfluoresceinsuccinimidyl-ester (CFSE) and measured their proliferative history by dye dilution, and observed no difference in CFSE dilution between Ex7 and control stromal cultures (Fig. 7c) . In contrast, Annexin V-staining revealed a significant increase in thymic progenitor apoptosis in the absence of mKitL, which could be reversed by the addition of the Q-VD-OPh pan-caspase inhibitor (Fig. 7d,e ), partially rescuing progenitor expansion (Fig. 7b ). Finally, to assess mKitL requirement for multi-potency, DN1 cells were plated on wild-type or mKitL-deficient stroma. Both generated, in addition to T cells, myeloid and other lymphoid lineages (Fig. 7f) . A key function of mKitL is therefore to promote the survival of early thymic progenitors by preventing caspase-dependent apoptosis, whereas it is dispensable for their proliferation and multi-lineage differentiation.
DISCUSSION
According to the current paradigm early stages of thymocyte development are supported by cTECs, which express ligands required for T cell lineage commitment and early T cell progenitor expansion 18, 33, 34 , whereas a niche role for thymic VECs was not previously explored. Here we show that several of these ligands (including Kitl, Cxcl12, Dll4, Jag1, Jag2) are highly expressed by a distinct, cortex-restricted subpopulation of thymic VECs. KitL + VECs are closely and selectively associated with DN1 thymocytes, and in agreement with this, loss of mKitL from thymic VECs results in a profound and selective decline in DN1 thymocyte numbers. Furthermore, as membrane-bound KitL is required for VECs to support c-Kit + thymic progenitors their niche function is mediated through direct cell-cell contact. Together, these results identify KitL + VECs as a critical niche cell type for the earliest thymic progenitors in the cortex. We also show that cTECs, but not mTECs, express KitL, and that TEC-specific loss of mKitL results in depletion of both DN1 and DN2 thymocytes. cTECs therefore collaborate with mKitL + VECs to generate niches for the earliest multi-potent c-Kit + ETPs by providing mKitL to support DN thymocyte development through dynamic, stage-specific cell-cell interaction.
The Kit receptor is exclusively expressed on DN1 and DN2 thymic progenitors, and in line with this, these progenitors were selectively reduced in mKitL VEC-and TEC-deleted mice, in agreement with previous studies of Sl/Sl mice 19 , whereas no effect on the differentiation of downstream DP, SP4 and SP8 thymocytes was observed, supporting that the decrease in thymic cellularity is due to depletion of the c-Kit + thymocyte progenitors in the absence of VEC-and TEC-expressed mKitL. In vitro mKitL was dispensable for proliferation and multi-lineage differentiation of c-Kit + ETPs, but prevented their caspase-dependent apoptosis. Although additional signals may regulate ETP survival in vivo, this indicates that promoting ETP survival is a key mKitL function, distinct from that provided by Notch signalling, which acts on the same populations to mediate T cell lineage restriction 8 . This complementarity of function is consistent with the observation that Notch ligands and KitL promote T-lymphopoiesis in a non-redundant manner in vivo when expressed in Foxn1 null TECs that otherwise fail to support T cell differentiation 33 .
The Sl d allele has been used to assign physiological function to mKitL in erythropoiesis, smooth muscle pacemaking and reproduction [25] [26] [27] , assuming that the Sl d allele does not significantly alter systemic KitL levels. This assumption was not previously tested, and when doing so we detected only trace levels of sKitL in compound Sl/Sl d mice. A significant component of the phenotypes associated with Sl d mutation could therefore be due to loss of systemic sKitL. Soluble KitL generated by the Sl d allele contains a carboxy-terminal peptide sequence additional to that generated through cleavage within the exon 6-encoded sequence 23, 24 . This does not affect its biological activity when produced recombinantly 23 , but clearly does affect in vivo availability. The soluble KitL generated by exon 7 deletion in the present study contains a distinct C-terminal extension peptide, and is both biologically active and physiologically stable. The KitL Ex7 allele will therefore be important for studies of the physiological role of mKitL.
VECs play important roles in tissue morphogenesis, regeneration and tissue stem cell maintenance 35 . In particular, KitL produced by VECs participates in the generation of embryonic haematopoietic clusters 36 and maintenance of haematopoietic stem cells 37 . However, as both sKitL and mKitL were depleted it remains unclear whether the observed effects were mediated systemically or in a niche context. In the case of the earliest thymocyte progenitors we now demonstrate that distinct VEC and cTEC mKitL-expressing niche cell types provide stage-specific support of early thymocyte progenitors: whereas mKitL produced by VECs is particularly critical for DN1 maintenance, cTEC-presented mKitL is required for maintaining DN2 cells. This requirement is reflected in the local organization of c-Kit + thymocyte progenitors, where DN1 thymocytes are selectively associated with KitL + VECs. Thymus-seeding progenitors are believed to enter the thymus at the cortico-medullary junction, where KitL + VECs are abundant on the cortical side. The initial dependence of c-Kit + thymocyte progenitors on KitL + VECs may therefore reflect their point of entry. They subsequently migrate away from the vasculature, becoming dependent on TEC-presented mKitL at the DN2 stage. As mKitL levels are lower in cTECs compared with KT + VECs, other factors are likely to control the migration process. This model for c-Kit + thymocyte niche cell interactions and dynamics is illustrated in Fig. 8 . It will be of interest to examine whether other differentiating progenitors exhibit similar dynamic interactions with supporting niche cells.
METHODS

Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb3299 METHODS Mouse lines. Pdgfb-iCreER T 2 transgenic mice were provided by M. Fruttiger 30 . Foxn1-Cre transgenic mice were provided by C. Blackburn 32 . Rosa26-CreER T 2 mice were provided by J. Nathans 38 . Sl/+ (stock number 000693) Sl d /+ (stock number 000160), Rosa26-EYFP reporter mice 31 (stock number 006148) and Tie2-Cre (ref. 29) (stock number 008863) transgenic mice were purchased from the Jackson Laboratory. Sl/Sl d mice were generated by intercrossing Sl/+ and Sl d /+ mice. The Sl d allele was re-sequenced to ensure that it retained the described genomic alteration 23, 24 .
To generate the Kitl-tdTomato transgene the RP24-73F12 BAC backbone (BacPac Resources, CHORI) was engineered by recombineering to replace the endogenous Kitl ATG and the remainder of exon 1 with a cassette composed of a hybrid intron (to allow for a controlled splicing event), a Kozak-ATG-CreER T2 moiety, an IRES followed by a myristoylated tdTomato dimer, and a SV40 polyA site. Insertion of the cassette was screened for with beta-galactosidase selection marker flanked by FRT sites. After successful clonal isolation and verification by sequencing, the marker gene was removed by bacterially expressed Flp-recombinase. No other modifications were applied to the BAC. DNA was prepared for injection using the Large Construct Kit (Qiagen, Hilden) and mice were generated by ICSI as described previously 39 .
The Kitl floxed exon 7-targeting vector was generated through recombinasemediated BAC shaving and insertion of a LoxP site into intron 6 and an FRT-neo-FRT-LoxP cassette into intron 7. Targeting was done by homologous recombination in IB10/C embryonic stem cells. After generation of chimaeras and germline transmission, the FRT-Neo-FRT cassette was recombined using the Rosa26-Flpe strain 40 , to generate the Kitl LEx7 allele.
All recombineered junctions and coding sequences were sequenced before transgenic lines were generated. Complete construct sequences are available on request.
Mouse lines were backcrossed to C57Bl/6 (>5 generations) where required, and maintained on this background. Male 4-6-week-old mice were used in all of the experiments. All mice were bred and maintained in accordance with UK Home Office regulations. Experimental protocols were approved by the Edinburgh University School of Biological Sciences Ethical Review Committee, and the Oxford University Clinical Medicine Ethical Review Committee. Mice were genotyped by PCR using the primers listed in Supplementary Table 1 .
Tamoxifen treatment. Tamoxifen (Sigma) was dissolved in ethanol at 60 mg ml −1 . The equivalent of 3 mg was mixed at a 1:1:2 ratio with Cremophor (Sigma) and PBS and injected subcutaneously twice, with a 2-day interval. Mice were analysed one week after the last injection, at an age of 4-5 weeks. We did not observe any toxicity of the inducible Cre, as no differences in thymic cellularity, DN1/DN2 cell number, bone marrow cellularity or lymphoid progenitor numbers were observed in tamoxifen-induced Pdgfb-CreERT2 mice compared with nontransgenic controls ( Supplementary Fig. 3g-j) . Likewise, no pronounced effect was observed of the tamoxifen treatment alone on thymocyte subsets with this setting ( Supplementary Fig. 3k ).
Thymic stromal cell preparation. Dissected thymuses were finely chopped and the obtained fragments digested in a mix of Collagenases I and 3 (Worthington; 3 mg ml −1 ), dispase II (Roche; 7 mg ml −1 ), DNase I (Invitrogen; 2 U ml −1 ) at 37 • C with gentle agitation for 20 min. The dissociated cells were centrifuged at 300g for 5 min and resuspended in ammonium chloride solution (Gey solution) for 1 min to lyse the erythrocytes and the reaction stopped by adding PBS, 5% FBS, 25 mM EDTA. To facilitate the thymic stromal cell sorting the samples were depleted of CD45 + cells by using the anti-mouse CD45 microbeads (Miltenyi). The FACS gating strategy is shown in Supplementary Fig. 7 . In the case of mesenchymal cells (MCs), the lack of CD45 + cells in this population was verified by establishing the absence of detectable Ptprc mRNA.
Primary thymic stromal cell-DN1 co-culture. Unfractionated thymic cells were prepared as described above (see Thymic stromal cell preparation). After the complete organ disaggregation the cells were resuspended in IMDM (Life Technologies/Gibco), 10% heat-inactivated FBS (Life Technologies/Gibco), 1% penicillin (Life Technologies/Gibco) and plated in collagen-treated plates. The collagen (Stem Cell Technologies) was diluted in PBS at 70 µg ml −1 final concentration and used to coat tissue culture-treated plates for 45 at room temperature. In vitro recombination was achieved by adding 1 µM 4-hydroxytamoxifen (SIGMA) to the culture every 2 days, by removing 50% of the medium volume and adding fresh medium back, for a total of 8 days. Before the DN1 seeding, the wells were extensively washed to remove all non-adherent cells and tamoxifen, and fresh medium was added.
CD4 and CD8 depletion. To prepare CD4/CD8-depleted thymocytes, thymuses were disaggregated as above and resuspended in 500 µl volume. Biotinylated anti-CD4 (eBioscience 10-0043) and anti-CD8 (eBioscience 13-0081) (0.5 µg ml −1 ) were added to the cells and left for 15 at 4 • C. The cells were washed and antibiotin microbeads (Miltenyi-10 µl × 10 8 ) added for 10 at 4 • C. The samples were then passed onto the AutoMacs machine by using the 'depletes' programme. CFSE labelling. The thymic cell suspension was resuspended at 10 × 10 6 cells ml −1 of PBS and CFSE was added to a final concentration of 1 µM, and cells incubated for 10 at room temperature in the dark. The labelling procedure was stopped by adding 5 volumes of FBS, followed by washing to remove excess dye.
Thymic section preparation and immunofluorescence. Freshly isolated thymuses were washed in PBS and included in OCT for snap freezing. The OCT blocks were sliced at 7 µm thickness and sections stored at −80 • C. The sections were dried at room temperature for 5 before fixing in acetone for 5 at 4 • C and left at room temperature for 5 to ensure acetone evaporation. The sections were then re-hydrated for 30 in PBS at room temperature and blocked in 5% BSA in PBS for 10 at room temperature. Fluorochrome-conjugated or unconjugated primary antibodies were diluted in PBS and sections stained for 1 h and then washed several times in PBS before adding the secondary antibody for 45 at room temperature. Sections were then counterstained with DAPI (0.2 µg ml −1 ) and mounted with DXP mounting medium (Fisher Scientific). Images were acquired with a Zeiss 780 confocal inverted microscope and processed using Fiji software.
To produce the randomized DN1 and DN2 simulation, two-dimensional images were generated using Fiji analysis software 41 . In each image, Gaussian blobs (σ = 3) of equal size to the DN1 and DN2 positive cells were placed randomly by sampling a uniform random distribution for the x and y coordinate position. In the original analysed images, the DN1 and DN2 staining was then removed and the staining replaced with the simulated images that contained 4 randomly positioned red cells (DN1) and 6 randomly distributed blue cells (DN2). The recombined images were then analysed by assessing the distance between the simulated DN1 (random, R-DN1) and DN2 (random, R-DN2) cells and the original CD31 + mKitL + VEC staining. Antibodies used for the immunofluorescence are listed in Supplementary Table 2 .
Flow cytometry of haematopoietic cells. Mouse T cells were isolated by meshing the thymuses on 70 µm cell strainers and resuspended in PBS, 5% FBS, 2 mM EDTA. A total of 25 × 10 6 cells were used for staining and analysis of the ETPs (gating strategy shown in Supplementary Fig. 8a ). Mouse bone marrow cells were isolated by crushing the bones in PBS, 5% FBS, 2 mM EDTA and the recovered cells filtered through 70 µm cell strainers. A total of 30 × 10 6 cells were used to stain and analyse the bone marrow lymphoid progenitor populations ( Supplementary Fig. 8b ). Data were acquired using LSR Fortessa (BD Biosciences) and analysed using FlowJo software. Sorting was performed by using a FACSAria III (BD Biosciences). The antibodies used are listed in Supplementary Table 3 .
RNA sequencing. Samples for RNA sequencing were prepared using the SMARTer Ultra Low RNA kit for Illumina Sequencing (Clontech) according to the manufacturer's instructions as previously described 42 . Briefly, cDNA libraries were prepared from 200 (VECs, cTECs and mTECs) cells, with 4-5 biological replicates from each genotype. Cells were sorted directly into lysis buffer supplemented with RNase Inhibitor (Clontech). The cDNA libraries were prepared according to the manufacturer's instructions with 15 cycles of amplification. Amplified cDNA libraries validated with a distinct peak spanning 400-9,000 bp in size as measured by the High Sensitivity DNA kit (Agilent) on an Agilent 2100 Bioanalyzer were further processed for RNA sequencing. Libraries were prepared for Illumina sequencing using the NexteraXT DNA Sample Preparation Kit (Illumina) using the manufacturer's recommended protocol. The size of the amplified fragments was confirmed by the Agilent High Sensitivity DNA kit (Agilent). Four to five samples with different indices were pooled per lane and sequenced on a HiSeq2000 (Illumina) generating single-end, 51-bp reads. These 51-bp reads were aligned against the mouse genome obtained from the build 37 assembly by NCBI (mm9) using Tophat2 (ref. 43). Non-uniquely mapped reads were discarded. Uniquely mapped reads were counted per exon of each RefSeq gene model and reads per kilobase of a concatenated exon length per million mapped reads (RPKMs) were calculated and assigned to each gene locus using custom R scripts.
Multiplex quantitative real-time PCR analysis of single cells.
For cDNA synthesis and preamplification of target genes the CellsDirect One-Step qRT-PCR kit (Invitrogen) was used. Cells were sorted directly into PCR plates or 0.2 ml PCR tubes containing 2.5 µl gene-specific 0.2× TaqMan gene expression assays (Applied Biosystems), 5 µl of CellsDirect 2× Reaction mix (Invitrogen), 1.2 µl CellsDirect RT/Taq mix, 1.2 µl TE buffer and 0.1 µl SUPERase-In RNase Inhibitor (Ambion) to a total volume of 10 µl. Conditions for reverse transcription and target gene amplification were: 15 min at 50 • C; 2 min at 95 • C; 22 cycles of 95 • C for 15 s and 60 • C for 4 min. Preamplified products were diluted 1:5 in TE buffer and analysed on a 48 × 48 Dynamic Array (Fluidigm) using the following PCR cycling condition: 95 • C for 10 min; 40 cycles of 95 • C for 15 s and 60 • C for 60 s. Data were analysed using the Ct method as described previously 44 ; results were normalized to B2m. Single cells not expressing Hprt or Actinb or B2m were excluded from the analysis. Taqman assays used for multiplexed quantitative real-time PCR are listed in Supplementary Table 4 .
Serum KitL measurements. Mouse serum samples were collected from peripheral blood clotted for 2 h at room temperature by centrifuging for 20 min at 2,000g and assessed by murine Kitl ELISA kits (R&D systems) according to the manufacturer's instructions. Optical density measurements were determined using a micro plate reader (Molecular Devices-SpectraMaxM2e) set to 450 nm with wavelength correction set to 570 nm. KitL PCR products were cloned using TOPO Cloning Kit PCR II-TOPO vector and then transformed into One Shot TOP10 Chemically Competent Cells (both Life Technologies). sKitl cDNA was inserted into a pMSCV-iresGFP plasmid by digesting with HpaI/XhoI and PvuI/XhoI (Fermentas/NEB) ligated using T4 DNA ligase and transformed into TOP10 Escherichia coli cells (both Life Technologies) according to the manufacturer's protocol. Sl d Kitl was subcloned into mKitl-pMSCV-iresGFP using BamHI, BglII and NsiI (Fermentas). Correct ligation of sKitl and Sl d Kitl into pMSCV-iresGFP vectors was confirmed by digestion with SpeI (NEB). Samples were sequenced using M13R and KitLR primers (M13R: 5 -CAG GAA ACA GCT ATG ACC-3 ; KitL cDNA R: 5 -GCC ACT GTG CGA AGG TAA C-3 ).
Human embryonic kidney (HEK) 293T/17 cells (293T, ATCC number: CRL-11268) cells were transfected with KitL-pMSCV-iGFP vectors in DMEM/10%FCS/1%PS using FuGene (Promega) according to the manufacturers' instructions. Transfected 293T cells were incubated in a humidified atmosphere in 5% CO 2 at 37 • C for 48 h. The supernatants from the transfected cells were collected and then evaluated for the level of sKitl by ELISA as described above. MC/9 cells (ATCC number: CRL-8306) were plated at 250,000 cells per well in a 96-well plate, cultured in 100 µl supernatant and incubated in a humidified atmosphere, 5% CO 2 at 37 • C for 48 h (Sanyo CO 2 incubator). CellTiter96r AQueous Non-Radioactive Cell Proliferation Assay MTS reagent (Promega) was then added to cells, incubated for 4 h (according to the manufacturer's instructions) and absorbance detected at 490 nm (Molecular Devices-SpectraMax M2e). Absorbance values were then used to calculate the percentage of maximum proliferation of cells (in relation to proliferation of cells in the recommended optimal medium: DMEM highglucose/10%FCS/10% rat T-STIM/0.05 mM β-mercaptoethanol). Cell lines were regularly screened for mycoplasma contamination. Cell line authentication was not performed.
Data reproducibility. For figures where representative images are shown, the number of times the experiments were repeated is as follows: Fig. 1a,d ,e: 4 times; Fig. 2a -l: 6 times; Fig. 2m -q: 3 times; Fig. 4a ,b,d,e,g: 6 times. Supplementary Fig. 3b Supplementary Table 5 . (d) Bioassay measuring proliferation of the KitL-dependent MC/9 cell line exposed to the supernatants from (c). Values are relative to MC/9 cells grown under optimal proliferation conditions. Error bars show standard errors. N=3 for each condition. For source data see Supplementary Table 5 . 
Tie2/Pdgfb 
